Carcinoid syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Ahmed Younes (talk | contribs) No edit summary |
|||
| (34 intermediate revisions by 4 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
The | The [[Incidence rate|incidence]] of [[Carcinoid Syndrome|carcinoid syndrome]] is estimated to be 2 cases per 100,000 individuals worldwide. [[Carcinoid Syndrome|Carcinoid syndrome]] is a [[disease]] that tends to affect the [[elderly]] population. The median [[age]] at diagnosis is 60.9 years.Females are more commonly affected with [[Carcinoid Syndrome|carcinoid syndrome]] than males. [[Carcinoid Syndrome|Carcinoid syndrome]] usually affects individuals of the caucasian race. African American, Latin American, and Asian individuals are less likely to develop [[Carcinoid Syndrome|carcinoid syndrome]]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | |||
*[[Carcinoid tumors]] represent about 0.5% of all newly diagnosed [[malignancies]]. | |||
*[[Carcinoid tumors]] account for 75% of all [[gastrointestinal]] [[endocrine tumors]]. | |||
*Carcinoid tumors represent about 0.5% of all newly diagnosed malignancies. | *[[Ovarian]] [[carcinoid tumors]] account for 0.3% of all [[Ovarian tumor|ovarian tumors]] and 0.5% of [[carcinoid tumors]].<ref>Ovarian carcinoid tumors. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/ovarian-carcinoid-tumours</ref> | ||
*Carcinoid tumors account for 75% of all gastrointestinal endocrine tumors. | ===Incidence=== | ||
*Ovarian carcinoid tumors account for 0.3% of all ovarian | *The incidence of [[Carcinoid Syndrome|carcinoid syndrome]] is estimated to be 2 cases per 100,000 individuals worldwide.<ref name="incidence">Epidemiology of carcinoid tumor. National cancer institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq</ref> | ||
. Radiopaedia | * [[Neuroendocrine tumor|Neuroendocrine tumors]] of the [[Digestive systems|digestive system]] arising in the [[Gastrointestinal|tubular gastrointestinal tract]] and the [[pancreas]] are relatively rare. | ||
*Ovarian carcinoid tumors are commonly seen in perimenopausal and postmenopausal women. | * The annual incidence in the United States is approximately 3.56 per 100,000 population.<ref name="pmid28448665">{{cite journal |vauthors=Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC |title=Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States |journal=JAMA Oncol |volume=3 |issue=10 |pages=1335–1342 |date=October 2017 |pmid=28448665 |pmc=5824320 |doi=10.1001/jamaoncol.2017.0589 |url=}}</ref> | ||
* | |||
===Age=== | |||
* | *[[Carcinoid Syndrome|Carcinoid syndrome]] is a [[disease]] that tends to affect th[[Elderly|e elderly p]]<nowiki/>opulation.<ref name="pmid15213627">{{cite journal| author=Maggard MA, O'Connell JB, Ko CY| title=Updated population-based review of carcinoid tumors. | journal=Ann Surg | year= 2004 | volume= 240 | issue= 1 | pages= 117-22 | pmid=15213627 | doi= | pmc=PMC1356383 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15213627 }} </ref> | ||
. Radiopaedia. http://radiopaedia.org/articles/thymic-carcinoid-tumour | *[[Ovarian]] [[carcinoid tumors]] are commonly seen in [[perimenopausal]] and [[postmenopausal]] [[women]]. | ||
*The median [[age]] at [[diagnosis]] is 60.9 years.<ref name="pmid15213627">{{cite journal| author=Maggard MA, O'Connell JB, Ko CY| title=Updated population-based review of carcinoid tumors. | journal=Ann Surg | year= 2004 | volume= 240 | issue= 1 | pages= 117-22 | pmid=15213627 | doi= | pmc=PMC1356383 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15213627 }} </ref> | |||
===Gender=== | |||
*[[Females]] are more commonly affected with [[Carcinoid Syndrome|carcinoid syndrome]] than [[males]]. | |||
*[[Males]] are more commonly affected with [[thymic]] [[carcinoid tumor]] than females. The male to female ratio is approximately 3 to 1.<ref>Thymic carcinoid tumour. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/thymic-carcinoid-tumour</ref> | |||
===Race=== | |||
*[[Carcinoid Syndrome|Carcinoid syndrome]] usually affects individuals of the Caucasian race. | |||
*African American, Latin American, and Asian individuals are less likely to develop [[Carcinoid Syndrome|carcinoid syndrome]].<ref name="pmid15213627">{{cite journal| author=Maggard MA, O'Connell JB, Ko CY| title=Updated population-based review of carcinoid tumors. | journal=Ann Surg | year= 2004 | volume= 240 | issue= 1 | pages= 117-22 | pmid=15213627 | doi= | pmc=PMC1356383 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15213627 }} </ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category: | [[Category:Gastroenterology]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Pulmonology]] | ||
[[Category:Hematology]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 20:35, 1 May 2019
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome epidemiology and demographics |
|
Carcinoid syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Carcinoid syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The incidence of carcinoid syndrome is estimated to be 2 cases per 100,000 individuals worldwide. Carcinoid syndrome is a disease that tends to affect the elderly population. The median age at diagnosis is 60.9 years.Females are more commonly affected with carcinoid syndrome than males. Carcinoid syndrome usually affects individuals of the caucasian race. African American, Latin American, and Asian individuals are less likely to develop carcinoid syndrome.
Epidemiology and Demographics
Prevalence
- Carcinoid tumors represent about 0.5% of all newly diagnosed malignancies.
- Carcinoid tumors account for 75% of all gastrointestinal endocrine tumors.
- Ovarian carcinoid tumors account for 0.3% of all ovarian tumors and 0.5% of carcinoid tumors.[1]
Incidence
- The incidence of carcinoid syndrome is estimated to be 2 cases per 100,000 individuals worldwide.[2]
- Neuroendocrine tumors of the digestive system arising in the tubular gastrointestinal tract and the pancreas are relatively rare.
- The annual incidence in the United States is approximately 3.56 per 100,000 population.[3]
Age
- Carcinoid syndrome is a disease that tends to affect the elderly population.[4]
- Ovarian carcinoid tumors are commonly seen in perimenopausal and postmenopausal women.
- The median age at diagnosis is 60.9 years.[4]
Gender
- Females are more commonly affected with carcinoid syndrome than males.
- Males are more commonly affected with thymic carcinoid tumor than females. The male to female ratio is approximately 3 to 1.[5]
Race
- Carcinoid syndrome usually affects individuals of the Caucasian race.
- African American, Latin American, and Asian individuals are less likely to develop carcinoid syndrome.[4]
References
- ↑ Ovarian carcinoid tumors. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/ovarian-carcinoid-tumours
- ↑ Epidemiology of carcinoid tumor. National cancer institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq
- ↑ Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC (October 2017). "Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States". JAMA Oncol. 3 (10): 1335–1342. doi:10.1001/jamaoncol.2017.0589. PMC 5824320. PMID 28448665.
- ↑ 4.0 4.1 4.2 Maggard MA, O'Connell JB, Ko CY (2004). "Updated population-based review of carcinoid tumors". Ann Surg. 240 (1): 117–22. PMC 1356383. PMID 15213627.
- ↑ Thymic carcinoid tumour. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/thymic-carcinoid-tumour